167

Cardiovascular Diseases
Focuses on heart and vascular health.
Sub Categories on Cardiovascular Diseases
Latest Articles
Researchers identify potential drug targets for future heart failure therapeutics

Researchers identify potential drug targets for future heart failure therapeutics

byMass General BrighamCredit: CC0 Public DomainHeart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified int

Researchers identify potential drug targets for future heart failure therapeutics

byMass General BrighamCredit: CC0 Public DomainHeart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified int
30-year risk of cardiovascular disease may help inform blood pressure treatment decisions

30-year risk of cardiovascular disease may help inform blood pressure treatment decisions

byAmerican Heart AssociationCredit: Pavel Danilyuk from PexelsA comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) sugg

30-year risk of cardiovascular disease may help inform blood pressure treatment decisions

byAmerican Heart AssociationCredit: Pavel Danilyuk from PexelsA comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) sugg
Born to heal: Why babies recover, but adults scar, after heart damage

Born to heal: Why babies recover, but adults scar, after heart damage

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNewborns with heart complications can rely on their newly developed immune systems to regenerate cardiac tissues, but adults aren't

Born to heal: Why babies recover, but adults scar, after heart damage

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNewborns with heart complications can rely on their newly developed immune systems to regenerate cardiac tissues, but adults aren't
Heart rate variability not a reliable marker of aggression

Heart rate variability not a reliable marker of aggression

Heart rate variability not a reliable marker of aggressionbyUniversity of St AndrewsIllustration of the hypothesized and examined links between vagal tone, HRV, and reactive aggression in aggres

Heart rate variability not a reliable marker of aggression

Heart rate variability not a reliable marker of aggressionbyUniversity of St AndrewsIllustration of the hypothesized and examined links between vagal tone, HRV, and reactive aggression in aggres
What you need to know about the new implants to patch up failing hearts. Are they really a 'breakthrough'?

What you need to know about the new implants to patch up failing hearts. Are they really a 'breakthrough'?

by John Martin,The ConversationCredit: Unsplash/CC0 Public DomainThere are many difficulties in converting any biological research into a medicine that will treat patients. Because of the comple

What you need to know about the new implants to patch up failing hearts. Are they really a 'breakthrough'?

by John Martin,The ConversationCredit: Unsplash/CC0 Public DomainThere are many difficulties in converting any biological research into a medicine that will treat patients. Because of the comple
Transcatheter PDA closure increasingly used for very low birth-weight infants

Transcatheter PDA closure increasingly used for very low birth-weight infants

by Elana GotkineFor very low birth-weight (VLBW) infants, transcatheter closure of the patent ductus arteriosus (PDA) is increasingly used, with selected short-term outcomes slightly more favorable, a

Transcatheter PDA closure increasingly used for very low birth-weight infants

by Elana GotkineFor very low birth-weight (VLBW) infants, transcatheter closure of the patent ductus arteriosus (PDA) is increasingly used, with selected short-term outcomes slightly more favorable, a
Therapeutic designer peptide to combat acute heart muscle weakness

Therapeutic designer peptide to combat acute heart muscle weakness

by Tina Bergmann, Universitätsklinikum HeidelbergModeling of S100A1ct interaction with SERCA2a transmembrane helices. Credit:Circulation(2024). DOI: 10.1161/CIRCULATIONAHA.123.066961Resear

Therapeutic designer peptide to combat acute heart muscle weakness

by Tina Bergmann, Universitätsklinikum HeidelbergModeling of S100A1ct interaction with SERCA2a transmembrane helices. Credit:Circulation(2024). DOI: 10.1161/CIRCULATIONAHA.123.066961Resear